Litcius/Paper detail

Prophylactic levosimendan in patients with low ejection fraction undergoing coronary artery bypass grafting: A pooled analysis of two multicentre randomised controlled trials

Thibaut Caruba, Anaïs Charles‐Nelson, John H. Alexander, Rajendra H. Mehta, Matthias Heringlake, Wolfgang Toller, Amélie Yavchitz, Brigitte Sabatier, Gilles Châtellier, Bernard Cholley

2022Anaesthesia Critical Care & Pain Medicine18 citationsDOIOpen Access PDF

Topics & Concepts

MedicineLevosimendanEjection fractionHazard ratioPlaceboSubgroup analysisCardiologyRandomized controlled trialInternal medicineHeart failurePopulationCoronary artery bypass surgeryArteryAnesthesiaSurgeryMeta-analysisConfidence intervalPathologyEnvironmental healthAlternative medicineHeart Failure Treatment and ManagementCardiac Valve Diseases and TreatmentsCardiac, Anesthesia and Surgical Outcomes
Prophylactic levosimendan in patients with low ejection fraction undergoing coronary artery bypass grafting: A pooled analysis of two multicentre randomised controlled trials | Litcius